Regeneron Pharmaceuticals, Inc. (ETR:RGO)

Regeneron Pharmaceuticals Revenue

Regeneron Pharmaceuticals had revenue of $3.75B USD in the quarter ending September 30, 2025, with 0.90% growth. This brings the company's revenue in the last twelve months to $14.25B, up 2.89% year-over-year. In the year 2024, Regeneron Pharmaceuticals had annual revenue of $14.20B with 8.27% growth.

• Revenue (ttm): $14.25B
• Revenue Growth: +2.89%
• P/S Ratio: 5.68
• Revenue / Employee: $943.19K
• Employees: 15,106
• Market Cap: 69.03B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	14.20B	1.08B	8.27%
Dec 31, 2023	13.12B	944.30M	7.76%
Dec 31, 2022	12.17B	-3.90B	-24.26%
Dec 31, 2021	16.07B	7.57B	89.14%
Dec 31, 2020	8.50B	1.94B	29.58%
Dec 31, 2019	6.56B	1.41B	27.44%
Dec 31, 2018	5.15B	-726.60M	-12.37%
Dec 31, 2017	5.87B	1.01B	20.82%
Dec 31, 2016	4.86B	756.67M	18.44%
Dec 31, 2015	4.10B	1.28B	45.55%
Dec 31, 2014	2.82B	714.81M	33.96%
Dec 31, 2013	2.10B	726.27M	52.69%
Dec 31, 2012	1.38B	932.65M	209.20%
Dec 31, 2011	445.82M	-13.25M	-2.89%
Dec 31, 2010	459.07M	79.81M	21.04%
Dec 31, 2009	379.27M	140.81M	59.05%
Dec 31, 2008	238.46M	113.43M	90.73%
Dec 31, 2007	125.02M	61.58M	97.05%
Dec 31, 2006	63.45M	-2.75M	-4.15%
Dec 31, 2005	66.19M	-	-